Kaitlyn Melanie Arsenault Skye Bioscience, Inc. (SKYE) insider trading activity
Kaitlyn Melanie Arsenault is Chief Financial Officer of Skye Bioscience, Inc.. Currently has a direct ownership of 166,342 shares of SKYE, which is worth approximately $751,865. The most recent transaction as insider was on Nov 18, 2024, when has been sold 43,206 shares (Common Stock) at a price of $4.99 per share, resulting in proceeds of $215,597. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
166K
21.07%
3M change
10.44%
12M change
Total Value Held
$751,865
Kaitlyn Melanie Arsenault Transaction History
KMA
Kaitlyn Melanie Arsenault
Chief Financial Officer
San Diego, CA